Exelixis, Inc. (EXEL): Price and Financial Metrics
Exelixis, Inc. (EXEL)
Today's Latest Price: $17.67 USD
1.15 (6.96%)
Updated Apr 6 4:00pm
Add EXEL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EXEL Stock Summary
- The ratio of debt to operating expenses for Exelixis Inc is higher than it is for about merely 12.64% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.11 for Exelixis Inc; that's greater than it is for merely 8.92% of US stocks.
- With a year-over-year growth in debt of 294.24%, Exelixis Inc's debt growth rate surpasses 93.58% of about US stocks.
- Stocks that are quantitatively similar to EXEL, based on their financial statements, market capitalization, and price volatility, are SILC, AKCA, JNCE, GNTX, and CDNS.
- Visit EXEL's SEC page to see the company's official filings. To visit the company's web site, go to www.exelixis.com.
EXEL Daily Price Range
EXEL 52-Week Price Range
EXEL Stock Price Chart More Charts
EXEL Price/Volume Stats
| Current price | $17.67 | 52-week high | $24.58 |
| Prev. close | $16.52 | 52-week low | $13.67 |
| Day low | $16.76 | Volume | 6,164,169 |
| Day high | $17.69 | Avg. volume | 3,769,510 |
| 50-day MA | $17.97 | Dividend yield | N/A |
| 200-day MA | $18.54 | Market Cap | 5.40B |
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
Top Stories View All
Best & Worst Performing Stock Industries for April 6, 2020
Best & Worst Performing Small Cap Stocks for April 6, 2020
Best & Worst Performing Mid Cap Stocks for April 6, 2020
Best & Worst Performing Large Cap Stocks for April 6, 2020
Best & Worst Performing Mega Cap Stocks for April 6, 2020
View All Top Stories
Loading social stream, please wait...